— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

Remedium Capital Partners, LLC

Q2 2026 · Filed 2026-08-07
Market Value
$452M
+60.6%
Holdings
7
+1
New Purchases
1
Added To
2
Closed
1
Reduced
0
Top 10 Concentration
100.0%
Turnover
28.6%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ORKA 32.99% 27.31% +5.68% $149M
SYRE 28.78% 26.13% +2.66% $130M
CBIO 1.44% 0.00% +1.44% $7M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
GLTO 11.78% 18.84% -7.06% $53M
GLYC 0.00% 2.36% -2.36% $0
APGE 17.24% 17.47% -0.23% $78M
JBIO 7.76% 7.88% -0.12% $35M

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 3 $357M 79.0%
Small Cap 3 $42M 9.2%
Micro Cap 1 $53M 11.8%

Portfolio Analytics

Avg Market Cap
$3.4B
Median Market Cap
$1.0B
Avg P/E
—
Median P/E
—
Avg Dividend Yield
—%
Avg Beta
1.27
# Stocks
7
# ETFs / Funds
0

Top Holdings (7 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 ORKA 32.99% 1,565,661 $149M $95.17 $72M — —
2 SYRE 28.78% 1,464,169 $130M $88.78 $57M +7,938 +0.6%
3 APGE 17.24% 586,691 $78M $132.73 $29M +3,100 +0.5%
4 GLTO 11.78% 2,045,473 $53M $26.01 $225K — —
5 JBIO 7.76% 1,577,750 $35M $22.22 $13M — —
6 CBIO 1.44% 361,250 $7M $18.00 — +361,250 — NEW
7 GLYC —% — — — -$7M -361,250 -100.0% SOLD

New Positions

SymbolValue% Port
CBIO $7M 1.44%

Sold Out Positions

SymbolValue% Port
GLYC — —%
View SEC EDGAR Filings for Remedium Capital Partners, LLC →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms